Takeda Pharmaceutical Company Limited (TAK)
USD 13.11
(-1.87%)
USD 13.11
(-1.87%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 4476.5 Billion JPY | 10.73% |
| 2023 | 4042.74 Billion JPY | -2.38% |
| 2022 | 4141.41 Billion JPY | -10.23% |
| 2021 | 4613.21 Billion JPY | 2.37% |
| 2020 | 4506.48 Billion JPY | -5.45% |
| 2019 | 4766 Billion JPY | 383.54% |
| 2018 | 985.64 Billion JPY | 64.31% |
| 2017 | 599.86 Billion JPY | 11.13% |
| 2016 | 539.76 Billion JPY | -14.24% |
| 2015 | 629.41 Billion JPY | -10.67% |
| 2014 | 704.58 Billion JPY | 26.72% |
| 2013 | 556.01 Billion JPY | 74.92% |
| 2012 | 317.86 Billion JPY | 1999.89% |
| 2011 | 15.13 Billion JPY | -2.46% |
| 2010 | 15.51 Billion JPY | -6.23% |
| 2009 | 16.55 Billion JPY | 1224.0% |
| 2008 | 1.25 Billion JPY | -39.02% |
| 2007 | 2.05 Billion JPY | -40.97% |
| 2006 | 3.47 Billion JPY | -37.55% |
| 2005 | 5.56 Billion JPY | 19.31% |
| 2004 | 4.66 Billion JPY | -4.21% |
| 2003 | 4.86 Billion JPY | -11.4% |
| 2002 | 5.49 Billion JPY | -17.43% |
| 2001 | 6.65 Billion JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 FY | 4476.5 Billion JPY | 10.73% |
| 2024 Q4 | 4476.5 Billion JPY | 4.25% |
| 2024 Q3 | 4293.87 Billion JPY | -2.51% |
| 2024 Q1 | 4330.25 Billion JPY | 12.64% |
| 2024 Q2 | 4404.36 Billion JPY | -12.2% |
| 2023 Q3 | 3914.88 Billion JPY | -6.08% |
| 2023 Q2 | 4168.41 Billion JPY | -3.52% |
| 2023 FY | 4042.74 Billion JPY | -2.38% |
| 2023 Q1 | 4320.35 Billion JPY | 4.32% |
| 2023 Q4 | 4042.74 Billion JPY | 3.27% |
| 2022 Q3 | 4231.93 Billion JPY | 5.36% |
| 2022 Q1 | 4381.58 Billion JPY | -5.02% |
| 2022 Q2 | 4016.47 Billion JPY | -8.33% |
| 2022 FY | 4141.41 Billion JPY | -10.23% |
| 2022 Q4 | 4141.41 Billion JPY | -2.14% |
| 2021 Q1 | 4494.22 Billion JPY | -0.27% |
| 2021 FY | 4613.21 Billion JPY | 2.37% |
| 2021 Q2 | 4631.41 Billion JPY | 3.05% |
| 2021 Q4 | 4613.21 Billion JPY | 3.28% |
| 2021 Q3 | 4466.57 Billion JPY | -3.56% |
| 2020 Q2 | 4853.21 Billion JPY | -5.43% |
| 2020 Q1 | 5131.98 Billion JPY | 7.68% |
| 2020 Q3 | 4610.05 Billion JPY | -5.01% |
| 2020 Q4 | 4506.48 Billion JPY | -2.25% |
| 2020 FY | 4506.48 Billion JPY | -5.45% |
| 2019 Q4 | 4766 Billion JPY | 96.29% |
| 2019 Q2 | 879.62 Billion JPY | -11.49% |
| 2019 Q1 | 993.78 Billion JPY | 0.83% |
| 2019 FY | 4766 Billion JPY | 383.54% |
| 2019 Q3 | 2428.04 Billion JPY | 176.03% |
| 2018 Q4 | 985.64 Billion JPY | -1.28% |
| 2018 FY | 985.64 Billion JPY | 64.31% |
| 2018 Q3 | 998.46 Billion JPY | 0.11% |
| 2018 Q2 | 997.36 Billion JPY | 5.97% |
| 2018 Q1 | 941.21 Billion JPY | 56.9% |
| 2017 Q4 | 599.86 Billion JPY | -18.94% |
| 2017 Q3 | 740.05 Billion JPY | 0.03% |
| 2017 Q1 | 739.77 Billion JPY | 37.06% |
| 2017 Q2 | 739.79 Billion JPY | 0.0% |
| 2017 FY | 599.86 Billion JPY | 11.13% |
| 2016 Q2 | 629.04 Billion JPY | -0.65% |
| 2016 Q4 | 539.76 Billion JPY | -14.34% |
| 2016 FY | 539.76 Billion JPY | -14.24% |
| 2016 Q3 | 630.12 Billion JPY | 0.17% |
| 2016 Q1 | 633.18 Billion JPY | 0.6% |
| 2015 Q3 | 731.08 Billion JPY | 2.28% |
| 2015 Q1 | 702.55 Billion JPY | -0.29% |
| 2015 Q4 | 629.41 Billion JPY | -13.91% |
| 2015 Q2 | 714.76 Billion JPY | 1.74% |
| 2015 FY | 629.41 Billion JPY | -10.67% |
| 2014 Q4 | 704.58 Billion JPY | -10.82% |
| 2014 FY | 704.58 Billion JPY | 26.72% |
| 2014 Q3 | 790.08 Billion JPY | -0.0% |
| 2014 Q2 | 790.08 Billion JPY | 46.28% |
| 2014 Q1 | 540.12 Billion JPY | -2.86% |
| 2013 Q4 | 556.01 Billion JPY | 2.93% |
| 2013 FY | 556.01 Billion JPY | 74.92% |
| 2013 Q1 | 301.34 Billion JPY | -5.19% |
| 2013 Q2 | 540.29 Billion JPY | 79.29% |
| 2013 Q3 | 540.2 Billion JPY | -0.02% |
| 2012 Q3 | - JPY | 0.0% |
| 2012 Q4 | 317.86 Billion JPY | 0.0% |
| 2012 FY | 317.86 Billion JPY | 1999.89% |
| 2012 Q1 | - JPY | -100.0% |
| 2012 Q2 | - JPY | 0.0% |
| 2011 Q2 | - JPY | 0.0% |
| 2011 Q3 | - JPY | 0.0% |
| 2011 Q4 | 15.13 Billion JPY | 0.0% |
| 2011 FY | 15.13 Billion JPY | -2.46% |
| 2011 Q1 | - JPY | -100.0% |
| 2010 Q4 | 15.51 Billion JPY | 0.0% |
| 2010 Q3 | - JPY | 0.0% |
| 2010 Q2 | - JPY | 0.0% |
| 2010 FY | 15.51 Billion JPY | -6.23% |
| 2009 FY | 16.55 Billion JPY | 1224.0% |
| 2009 Q4 | 16.55 Billion JPY | 0.0% |
| 2009 Q3 | - JPY | 0.0% |
| 2008 FY | 1.25 Billion JPY | -39.02% |
| 2007 FY | 2.05 Billion JPY | -40.97% |
| 2006 FY | 3.47 Billion JPY | -37.55% |
| 2005 FY | 5.56 Billion JPY | 19.31% |
| 2004 FY | 4.66 Billion JPY | -4.21% |
| 2003 FY | 4.86 Billion JPY | -11.4% |
| 2002 FY | 5.49 Billion JPY | -17.43% |
| 2001 FY | 6.65 Billion JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 2.52 Billion USD | -177334.808% |
| Bausch Health Companies Inc. | 21.93 Billion USD | -20305.237% |
| Catalent, Inc. | 4.54 Billion USD | -98392.871% |
| Emergent BioSolutions Inc. | 446.5 Million USD | -1002475.812% |
| Elanco Animal Health Incorporated | 5.73 Billion USD | -77942.207% |
| Perrigo Company plc | 3.63 Billion USD | -123124.538% |
| Teva Pharmaceutical Industries Limited | 18.48 Billion USD | -24122.18% |
| Zoetis Inc. | 6.56 Billion USD | -68097.761% |